OTC:GRST
ETHEMA HEALTH Corp
ETHEMA HEALTH Corp (GRST) is a high-leverage healthcare entity showing revenue expansion but facing severe net losses and balance sheet stress.
Key Metrics
Investment Thesis
Bull Case
Investors might consider a speculative position if there is a pending equity restructuring or debt-for-equity swap that could recapitalize the balance sheet. The consistent revenue growth trajectory from 2022 to 2024 suggests underlying product demand remains intact despite current accounting losses. A potential spin-off or acquisition by a larger healthcare conglomerate could provide an exit multiple at current distressed levels.
Bear Case
The negative shareholders' equity and massive retained earnings deficit of -$44.4M indicate that the company has exhausted its internal capital resources for growth. Operating cash flow is negative, and the gap between total liabilities ($19.6M) and assets ($12.2M) creates a precarious solvency position. Without a clear path to profitability or external funding, the risk of delisting or liquidation remains elevated.
About ETHEMA HEALTH Corp
ETHEMA HEALTH Corp (GRST) is a healthcare-focused entity operating within the broader medical sector, serving markets with specialized health solutions. The company reported revenue growth from $4.8M in 2022 to $6.0M in 2024, though profitability has faced significant headwinds. Key financial metrics indicate substantial accumulated deficits and high leverage relative to current assets.
Analysis
Management Discussion
While revenue expanded to $6.0M in 2024, the company recorded a net loss of -$2.2M and operating profit of -$1.3M, marking a sharp deterioration from prior years. Cash flow from financing of +$1.7M partially offset severe operational cash burn, yet the retained earnings deficit has ballooned to -$44.4M. The business appears to be relying heavily on external capital injections rather than organic internal generation.
Industry Overview
The healthcare services industry is currently characterized by regulatory scrutiny and high capital requirements for maintaining facility standards and equipment. Companies in this space often face margin compression due to rising operational costs and reimbursement rate adjustments from payers. The sector is seeing a consolidation trend where only entities with strong balance sheets can sustain long-term growth.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $4.8M | $5.3M | $6.0M |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $4.8M | $5.3M | $6.0M |
| Operating Expenses | $4.3M | $5.9M | $7.4M |
| Operating Income | $489.1K | $-541.9K | $-1.3M |
| G&A | $805.4K | $1.0M | $1.6M |
| D&A | $540.1K | $498.9K | $467.0K |
| Depreciation | $182.1K | $140.9K | $109.0K |
| Other OpEx | $3.5M | $4.8M | $5.8M |
| Non-Operating Income | $-81.7K | $1.2M | $-832.8K |
| Interest Income | $78 | $676 | $2.3K |
| Pre-Tax Income | $407.4K | $614.5K | $-2.2M |
| Income Tax | $-112.2K | $392.0K | $0 |
| Continuing Ops | $519.6K | $222.5K | $-2.2M |
| Discontinued Ops | $-224.4K | $783.9K | $0 |
| Net Income | $295.2K | $1.0M | $-2.2M |
| Minority Interest | $-47.3K | $0 | $0 |
| Net to Common | $342.5K | $1.0M | $-2.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $542.9K | $403.1K | $528.8K |
| Cash & Equivalents | $140.8K | $68.6K | $244.8K |
| Accounts Receivable | $337.1K | $313.3K | $260.8K |
| Other Current Assets | $65.1K | $21.2K | $23.1K |
| Long-Term Assets | $6.0M | $11.1M | $11.6M |
| PP&E (Net) | $3.0M | $508.4K | $699.7K |
| Operating Leases | $1.4M | $9.3M | $9.9M |
| Other LT Assets | $1.7M | $1.3M | $1.0M |
| Total Assets | $6.6M | $11.5M | $12.2M |
| Current Liabilities | $13.3M | $8.3M | $9.7M |
| Current Leases | $287.0K | $38.6K | $299.1K |
| Taxes Payable | $248.6K | — | — |
| Other Current Liab | $12.6M | $8.3M | $9.4M |
| Long-Term Liabilities | $2.1M | $9.4M | $10.0M |
| LT Operating Leases | $1.2M | $9.4M | $9.9M |
| Other LT Liab | $651.6K | $37.0K | $12.7K |
| Total Liabilities | $15.4M | $17.7M | $19.6M |
| Shareholders' Equity | $-9.2M | $-6.2M | $-7.5M |
| Paid-In Capital | $23.4M | $26.2M | $25.0M |
| Retained Earnings | $-43.5M | $-42.4M | $-44.4M |
| Total L&E | $6.6M | $11.5M | $12.2M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $295.2K | $1.0M | $-2.2M |
| Non-Cash Adjustments | $893.5K | $-1.2M | $1.4M |
| Working Capital Changes | $388.4K | $-324.5K | $317.4K |
| Cash from Operations | $1.6M | $-530.2K | $-455.7K |
| Capital Expenditures | — | $40.6K | $60.3K |
| Cash from Investing | $-712.3K | $2.5M | $-1.0M |
| Cash from Financing | $303.7K | $-2.1M | $1.7M |
| FX Effect | $-1.1M | $80.8K | $-35.0K |
| Net Change in Cash | $91.9K | $-72.2K | $176.2K |
| Beginning Cash | $48.8K | $140.8K | $68.6K |
| Ending Cash | $140.8K | $68.6K | $244.8K |
Frequently Asked Questions
How does ETHEMA HEALTH Corp make money?
The company's revenue streams are consolidated under a primary health services or product distribution segment, evidenced by the lack of cost of revenue separation which suggests a service-based or low-COGS model. The financials indicate operations are likely supported by significant non-cash depreciation and amortization adjustments ($467M), suggesting heavy asset utilization in medical infrastructure.
What are the main risks for GRST?
The company is deeply insolvent with total liabilities of $19.6M against negative shareholders' equity of -$7.5M, creating an immediate bankruptcy risk. Operating cash flow turned sharply negative at -$455K in the latest period, signaling liquidity distress despite positive net changes in cash on paper. High non-operating losses exceeding $830K suggest significant financial engineering costs or interest burdens eroding core operations.
What is GRST's competitive advantage?
The company maintains substantial paid-in capital of $25M, providing a cushion for potential strategic pivots or acquisitions. Its revenue has demonstrated consistent year-over-year growth over the last three years despite macroeconomic pressures. The entity holds significant long-term operating lease assets ($9.9M), indicating a committed footprint in physical healthcare facilities or equipment.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.